The Edge of the Patch Tells You Which Shampoo to Buy
Seborrhoeic dermatitis and scalp psoriasis both flake, both itch, and both start at the hairline — but one answers to an antifungal and the other mostly ignores it.
Read the preview
Is it psoriasis or seborrhoeic dermatitis on your scalp? Look at the edge. Seb derm scale fades into normal skin; a psoriasis plaque stops at a sharp border, often creeping onto forehead or ears. That matters — one answers to an antifungal, the other mostly ignores it. And why check your fingernails and joints too? The Dermington Gazette draws the line.
The flake tells you less than its border does
Most people trying to identify what is happening on their scalp stare at the flakes. It is the least informative thing available. Both of these conditions shed, both shed more when the scalp is dry or cold, and by the time material reaches a dark jumper it has been broken up enough to tell you almost nothing.
The border is where the information lives. Seborrhoeic dermatitis has no real edge — the greasy, yellowish, slightly damp-looking scale sits on skin that fades gradually into normal scalp, spread along the sebaceous map of the head: the hairline, the crown, behind the ears, and often continuing onto the brows, the folds beside the nose and the centre of the chest. Scalp psoriasis behaves differently. Its plaques are dry rather than greasy, the scale is thicker and more silver-white, and the patch stops. You can trace a margin with a fingertip, and that margin frequently continues past the hairline onto the forehead, over the ears or down the nape — a thing seb derm does not usually do in a sharply-drawn band.
Under magnification the separation gets crisper still. A trichoscopy study comparing 31 people with scalp psoriasis against 112 with seborrhoeic dermatitis found red dots and globules to be the characteristic pattern in psoriasis, with arborising red lines and comma vessels marking out seb derm; the authors added signet ring vessels and 'hidden hairs' as further psoriasis signs. You cannot see any of this with the naked eye, which is worth knowing for its own sake — the distinction is real and physical, it simply sits just above the resolution of a bathroom mirror. That is not a reason to guess. It is a reason to use the evidence you can see.
Look somewhere other than your head
The most useful diagnostic move in a scalp complaint is to stop looking at the scalp. Psoriasis is a systemic disease that happens to be visible on skin, and it leaves corroborating marks in places seb derm does not reach.
Check the fingernails first, in good light. Pitting — small punched-out depressions, as if the nail plate had been pressed with a pin — is a psoriasis sign; so is onycholysis, where the nail lifts from its bed leaving a white or yellow-brown separation, and the 'oil drop' patch of salmon discolouration under the plate. Then check the extensor surfaces: elbows, knees, shins. Then the intergluteal cleft and the navel, which people never think to look at and which is a classic quiet site.
These are not just clues, they carry prognostic weight. A population-based cohort followed 1,593 people with psoriasis over 20,936 person-years and recorded who went on to develop psoriatic arthritis. Cumulative incidence was 1.7% at five years, 3.1% at ten and 5.1% at twenty. The features that raised the risk were scalp lesions, at a hazard ratio of 3.89, nail dystrophy at 2.93, and intergluteal or perianal involvement at 2.35. If your scalp complaint turns out to be psoriasis, that is a reason to pay attention to persistent morning stiffness, a swollen finger or toe, or heel pain that has no injury behind it — the Psoriatic Arthritis Screen exists for exactly this checkpoint, and the psoriasis pathway sets out where that leads. Seborrhoeic dermatitis carries no such association, which is part of why the distinction is worth more than shampoo shopping.
Why the antifungal aisle works on one and not the other
The mechanisms are not adjacent. Seborrhoeic dermatitis is driven by an inflammatory response to Malassezia, a lipophilic yeast that lives on everyone and feeds on sebum; reduce the yeast load and the inflammation follows it down. Psoriasis is an immune-mediated disease in which T-cell signalling drives keratinocytes to proliferate far faster than they should. There is no yeast at the centre of it, so there is nothing for an antifungal to remove.
The trial evidence tracks that logic almost exactly. A Cochrane review of topical antifungals for seborrhoeic dermatitis pooled 51 studies and 9,052 participants. Ketoconazole 2% produced a 31% lower risk of failed clearance than placebo at four weeks (RR 0.69, 95% CI 0.59–0.81), and — the finding that ought to change more shopping decisions — achieved remission rates comparable to topical steroids (RR 1.17) with 44% fewer side effects (RR 0.56). Ciclopirox 1% performed similarly against placebo. For a genuine seb derm scalp, Nizoral Anti-Dandruff Shampoo is the first thing to try properly, with Vanicream Dandruff Shampoo or a selenium sulfide option like Head & Shoulders Clinical Strength Advanced Oil Control as rotation partners when the yeast stops responding to one agent. The dandruff and seb derm pathway covers how to rotate without losing the thread.
For scalp psoriasis the drug hierarchy is entirely different. A Cochrane review of 59 randomised trials and 11,561 participants found topical corticosteroids clearly ahead of vitamin D analogues for clearance (RR 1.82, number needed to treat 8), with the two-compound steroid-and-vitamin-D combination beating steroid monotherapy by a statistically real but small margin (NNTB 17). Notably, steroids of moderate, high and very high potency performed similarly — escalating potency is not the lever people assume it is. Equally notable is what that review could not assess: the authors flagged inherent limitations in evaluating salicylic acid, tar and dithranol, which is to say the over-the-counter half of the psoriasis shelf is the least well-studied part of the whole field.
The scale is not just a symptom, it is the obstacle
Here is the practical failure that sinks more scalp psoriasis treatment than wrong-drug choice: a thick, adherent, silvery plaque is a physical barrier, and the medicated product applied on top of it never reaches the skin underneath. People conclude the steroid failed. The steroid never arrived.
Descaling is therefore a delivery step, not a cosmetic one, and it comes first. A keratolytic loosens the bond between corneocytes so the plaque can lift — salicylic acid is the workhorse, whether as a shampoo like DHS Sal Shampoo or Neutrogena T/Sal, or as a leave-on for the stubborn patches such as The INKEY List Salicylic Acid Exfoliating Scalp Treatment. Coal tar preparations like DHS Tar Shampoo work on a different mechanism, slowing keratinocyte proliferation, and have decades of clinical use behind a thinner evidence base than their history suggests. Salicylic acid is worth understanding as a category, because the same molecule is doing something different here than it does in an acne product.
Whatever you choose, the variable people get wrong is contact time. A shampoo that touches the scalp for twenty seconds before rinsing has not been used; it has been rinsed off. Work it onto the scalp itself rather than the hair, leave it for five to ten minutes, and treat the whole scalp rather than only the patches you can feel — the boundary of a plaque is not where the disease stops. The dry-scalp question is worth reading if you are still unsure which of these you are treating.
Sebopsoriasis, and the honest overlap
Any article that presents this as a clean binary is oversimplifying, so here is the messy part. There is a genuine in-between — sebopsoriasis — with features of both, and there is nothing stopping a person from having ordinary seborrhoeic dermatitis and psoriasis at the same time. Scalps do not read the textbook.
That overlap has a useful consequence, though, because the two conditions respond so differently that the response itself is informative. If an adequately-used antifungal clears the greasy scale along the hairline and around the ears within a month but leaves a thick, sharply-edged plaque on the crown untouched, you have learned something no dermoscope told you. The reverse is also diagnostic: a scalp that improves under a keratolytic-plus-steroid regimen and relapses fast when the antifungal is dropped is telling you the yeast is still part of the picture.
This is where a log stops being tedious admin and starts being data. Record what you applied, how long you left it, and what the scalp looked like a week later — the Flare Diary is built for that pattern, and the sequence is far more legible in writing than in memory. It is also the difference between arriving at an appointment with 'nothing works' and arriving with 'four weeks of ketoconazole, ten minutes contact, cleared the hairline and did nothing to the crown', which is a diagnosis-shaped sentence.
When the shelf has genuinely had a fair trial
Before escalating, be strict about what a fair trial means, because most 'failed' over-the-counter courses were never really run. It means the right active for the condition you think you have, applied to the scalp rather than the hair, left on for five to ten minutes, used at the frequency on the label, over four weeks, on the whole scalp. Anything less and you are escalating on missing evidence.
If that trial genuinely fails, the escalation path is well-worn. For seb derm, prescription-strength antifungal shampoos, ciclopirox, or intermittent steroid scalp applications for the inflammatory component; the newer non-steroid topicals have widened the options for people who cannot use steroids on the face and hairline. For psoriasis, the standard next step is a potent corticosteroid in a scalp-appropriate vehicle — a solution, foam or gel, since creams and ointments are unusable in hair — or the two-compound calcipotriol-and-betamethasone preparation, whose modest statistical edge over steroid alone is real. How long you can stay on it is a fair question with a specific answer, and the same question for a seb derm scalp resolves differently.
One thing worth raising if you get as far as a specialist: scalp-limited psoriasis scores poorly on the standard severity instruments, because the scalp is a small share of body surface area and the arithmetic reflects that. Run the PASI Calculator on a scalp-only presentation and the number will look mild next to how the condition actually feels — a mismatch worth naming out loud in the appointment rather than accepting quietly, since visible, itchy, constantly-shedding disease at the hairline carries an impact the score was never designed to capture.
Each shelf lists every product in the catalogue built on the ingredient, graded live against your profile — the shelf stays current when a single pick would not.
Products named in this piece
Independently reviewed, with a verdict per concern — the real products behind this piece.
- Therapy guide Dandruff Rotation and escalation for the yeast-driven end
- Therapy guide Psoriasis Where scalp psoriasis sits in the wider treatment ladder
- Question Is this dandruff or just a dry scalp? For readers still unsure which condition they are treating
- Question How long is too long on a scalp steroid? Duration limits on the seb derm side
- Question How long can I keep using the steroid? Duration limits on the psoriasis side
References
- Topical antifungals for seborrhoeic dermatitis — Cochrane Database of Systematic Reviews, 2015
- Topical treatments for scalp psoriasis — Cochrane Database of Systematic Reviews, 2016
- Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study — Arthritis & Rheumatism, 2009
- Dermoscopic findings in scalp psoriasis and seborrheic dermatitis; two new signs; signet ring vessel and hidden hair — Indian Journal of Dermatology, 2015
- Diagnostic Accuracy of Trichoscopy in Inflammatory Scalp Diseases: A Systematic Review — Dermatology, 2022
Every cited link is verified to resolve to the paper named. Where a source could not be independently confirmed, it is listed without a link rather than pointing you somewhere wrong.
Frequently asked
What is the single most reliable way to tell scalp psoriasis from seb derm at home?
Look at the border rather than the flake. Seborrhoeic dermatitis fades gradually into normal scalp and follows the greasy zones — hairline, ears, brows, sides of the nose. A psoriasis plaque has a traceable edge, feels thicker and drier, and frequently extends a centimetre or two past the hairline in a defined band.
Why do my fingernails matter for a scalp problem?
Because psoriasis leaves evidence in more than one place. Pitting, nail lifting and salmon-coloured 'oil drop' patches support a psoriasis diagnosis, and nail dystrophy carried a hazard ratio of 2.93 for later psoriatic arthritis in a long-running population cohort. Seborrhoeic dermatitis does not affect nails.
Will an antifungal shampoo help scalp psoriasis at all?
Marginally at best, and not through the intended mechanism. Antifungals reduce Malassezia, which drives seb derm but is not the engine of psoriasis. If an antifungal helps a psoriatic scalp somewhat, the likeliest explanation is that seborrhoeic dermatitis is present alongside it — which is common enough to have its own name, sebopsoriasis.
How long should a medicated shampoo sit on the scalp?
Five to ten minutes, worked into the scalp rather than the hair. A twenty-second lather has not delivered the active in any meaningful sense. Contact time is the most common reason a correctly-chosen shampoo appears to fail, and it costs nothing to fix.
Do I need a stronger steroid if a moderate one isn't clearing my plaques?
Not necessarily. In the pooled scalp psoriasis trials, moderate, high and very high potency steroids performed similarly. The more likely bottleneck is thick adherent scale blocking the drug, which is why a keratolytic step comes first, and the vehicle — a solution, foam or gel rather than a cream — matters in hair.
My scalp psoriasis is severe but my PASI score is low. How is that possible?
PASI weights body surface area, and the scalp is a small percentage of it, so scalp-limited disease scores mild almost by construction. The score is measuring extent, not burden. It is a legitimate thing to raise directly in an appointment when the number and your experience disagree.